Does the media favor PAGS or EVH?

In the previous week, PagSeguro Digital had 2 more articles in the media than Evolent Health. MarketBeat recorded 3 mentions for PagSeguro Digital and 1 mentions for Evolent Health. Evolent Health's average media sentiment score of 1.00 beat PagSeguro Digital's score of 0.76 indicating that Evolent Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PagSeguro Digital 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Evolent Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor PAYO or EVH?

In the previous week, Payoneer Global had 3 more articles in the media than Evolent Health. MarketBeat recorded 4 mentions for Payoneer Global and 1 mentions for Evolent Health. Evolent Health's average media sentiment score of 1.00 beat Payoneer Global's score of 0.60 indicating that Evolent Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Payoneer Global 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Evolent Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation & earnings, EVH or VVX?

V2X has higher revenue and earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than V2X, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Evolent Health $1.88B 0.33 -$534.51M -$4.76 N/A V2X $4.48B 0.54 $77.88M $2.79 27.45

Is EVH or VVX more profitable?

V2X has a net margin of 1.88% compared to Evolent Health's net margin of -26.29%. V2X's return on equity of 16.94% beat Evolent Health's return on equity. Company Net Margins Return on Equity Return on Assets Evolent Health -26.29% 0.36% 0.10% V2X 1.88% 16.94% 5.74%

Does the media prefer EVH or VVX?

In the previous week, Evolent Health and Evolent Health both had 1 articles in the media. Evolent Health's average media sentiment score of 1.00 beat V2X's score of 0.00 indicating that Evolent Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Evolent Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive V2X 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor EVH or FLYW?

In the previous week, Flywire had 1 more articles in the media than Evolent Health. MarketBeat recorded 2 mentions for Flywire and 1 mentions for Evolent Health. Evolent Health's average media sentiment score of 1.00 beat Flywire's score of 0.93 indicating that Evolent Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Evolent Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Flywire 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Evolent Health (EVH) Competitors

$5.58 +0.10 (+1.81%)

Closing price 07/8/2026 03:59 PM Eastern

Extended Trading

$5.60 +0.02 (+0.29%)

As of 07/8/2026 07:59 PM Eastern

Compare

EVH vs. PAGS, TNET, PAYO, VVX, and FLYW

Should you buy Evolent Health stock or one of its competitors? MarketBeat compares Evolent Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Evolent Health include PagSeguro Digital (PAGS), TriNet Group (TNET), Payoneer Global (PAYO), V2X (VVX), and Flywire (FLYW). These companies are all part of the "business services" industry.

How does Evolent Health compare to PagSeguro Digital?

PagSeguro Digital (NYSE:PAGS) and Evolent Health (NYSE:EVH) are both business services companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, media sentiment, dividends and analyst recommendations.

PagSeguro Digital has a beta of 1.32, indicating that its stock price is 32% more volatile than the broader market. Comparatively, Evolent Health has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market.

PagSeguro Digital has higher revenue and earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than PagSeguro Digital, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PagSeguro Digital	$3.65B	0.67	$379.40M	$1.36	6.43
Evolent Health	$1.88B	0.33	-$534.51M	-$4.76	N/A

PagSeguro Digital presently has a consensus price target of $12.00, indicating a potential upside of 37.22%. Evolent Health has a consensus price target of $6.08, indicating a potential upside of 8.92%. Given PagSeguro Digital's higher probable upside, equities analysts plainly believe PagSeguro Digital is more favorable than Evolent Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PagSeguro Digital	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25
Evolent Health	1 Sell rating(s)	4 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.65

In the previous week, PagSeguro Digital had 2 more articles in the media than Evolent Health. MarketBeat recorded 3 mentions for PagSeguro Digital and 1 mentions for Evolent Health. Evolent Health's average media sentiment score of 1.00 beat PagSeguro Digital's score of 0.76 indicating that Evolent Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PagSeguro Digital	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Evolent Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

45.9% of PagSeguro Digital shares are owned by institutional investors. 1.5% of Evolent Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

PagSeguro Digital has a net margin of 10.40% compared to Evolent Health's net margin of -26.29%. PagSeguro Digital's return on equity of 16.44% beat Evolent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PagSeguro Digital	10.40%	16.44%	3.29%
Evolent Health	-26.29%	0.36%	0.10%

Summary

PagSeguro Digital beats Evolent Health on 12 of the 16 factors compared between the two stocks.

How does Evolent Health compare to TriNet Group?

Evolent Health (NYSE:EVH) and TriNet Group (NYSE:TNET) are both business services companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, risk, institutional ownership, valuation and profitability.

TriNet Group has higher revenue and earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than TriNet Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evolent Health	$1.88B	0.33	-$534.51M	-$4.76	N/A
TriNet Group	$5.01B	0.50	$155M	$3.35	16.41

In the previous week, Evolent Health had 1 more articles in the media than TriNet Group. MarketBeat recorded 1 mentions for Evolent Health and 0 mentions for TriNet Group. Evolent Health's average media sentiment score of 1.00 beat TriNet Group's score of 0.50 indicating that Evolent Health is being referred to more favorably in the media.

Company	Overall Sentiment
Evolent Health	Positive
TriNet Group	Positive

96.8% of TriNet Group shares are held by institutional investors. 1.5% of Evolent Health shares are held by insiders. Comparatively, 40.0% of TriNet Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Evolent Health has a beta of 0.76, meaning that its share price is 24% less volatile than the broader market. Comparatively, TriNet Group has a beta of 0.99, meaning that its share price is 1% less volatile than the broader market.

Evolent Health presently has a consensus price target of $6.08, indicating a potential upside of 8.92%. TriNet Group has a consensus price target of $55.80, indicating a potential upside of 1.48%. Given Evolent Health's stronger consensus rating and higher possible upside, equities research analysts clearly believe Evolent Health is more favorable than TriNet Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evolent Health	1 Sell rating(s)	4 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.65
TriNet Group	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

TriNet Group has a net margin of 3.22% compared to Evolent Health's net margin of -26.29%. TriNet Group's return on equity of 219.54% beat Evolent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evolent Health	-26.29%	0.36%	0.10%
TriNet Group	3.22%	219.54%	5.42%

Summary

TriNet Group beats Evolent Health on 11 of the 16 factors compared between the two stocks.

How does Evolent Health compare to Payoneer Global?

Payoneer Global (NASDAQ:PAYO) and Evolent Health (NYSE:EVH) are both business services companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, media sentiment, valuation and risk.

82.2% of Payoneer Global shares are held by institutional investors. 2.1% of Payoneer Global shares are held by company insiders. Comparatively, 1.5% of Evolent Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Payoneer Global has a net margin of 6.76% compared to Evolent Health's net margin of -26.29%. Payoneer Global's return on equity of 11.10% beat Evolent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Payoneer Global	6.76%	11.10%	0.95%
Evolent Health	-26.29%	0.36%	0.10%

In the previous week, Payoneer Global had 3 more articles in the media than Evolent Health. MarketBeat recorded 4 mentions for Payoneer Global and 1 mentions for Evolent Health. Evolent Health's average media sentiment score of 1.00 beat Payoneer Global's score of 0.60 indicating that Evolent Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Payoneer Global	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Evolent Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Payoneer Global has a beta of 0.95, indicating that its stock price is 5% less volatile than the broader market. Comparatively, Evolent Health has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market.

Payoneer Global presently has a consensus target price of $7.40, indicating a potential upside of 4.37%. Evolent Health has a consensus target price of $6.08, indicating a potential upside of 8.92%. Given Evolent Health's stronger consensus rating and higher possible upside, analysts clearly believe Evolent Health is more favorable than Payoneer Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Payoneer Global	0 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.22
Evolent Health	1 Sell rating(s)	4 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.65

Payoneer Global has higher earnings, but lower revenue than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than Payoneer Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Payoneer Global	$1.05B	2.25	$73.19M	$0.20	35.45
Evolent Health	$1.88B	0.33	-$534.51M	-$4.76	N/A

Summary

Payoneer Global beats Evolent Health on 11 of the 16 factors compared between the two stocks.

How does Evolent Health compare to V2X?

Evolent Health (NYSE:EVH) and V2X (NYSE:VVX) are both business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, risk, analyst recommendations, valuation, institutional ownership, profitability, earnings and dividends.

95.2% of V2X shares are held by institutional investors. 1.5% of Evolent Health shares are held by insiders. Comparatively, 1.0% of V2X shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Evolent Health and Evolent Health both had 1 articles in the media. Evolent Health's average media sentiment score of 1.00 beat V2X's score of 0.00 indicating that Evolent Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Evolent Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
V2X	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

V2X has higher revenue and earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than V2X, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evolent Health	$1.88B	0.33	-$534.51M	-$4.76	N/A
V2X	$4.48B	0.54	$77.88M	$2.79	27.45

Evolent Health has a beta of 0.76, meaning that its share price is 24% less volatile than the broader market. Comparatively, V2X has a beta of 0.22, meaning that its share price is 78% less volatile than the broader market.

V2X has a net margin of 1.88% compared to Evolent Health's net margin of -26.29%. V2X's return on equity of 16.94% beat Evolent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evolent Health	-26.29%	0.36%	0.10%
V2X	1.88%	16.94%	5.74%

Evolent Health presently has a consensus price target of $6.08, suggesting a potential upside of 8.92%. V2X has a consensus price target of $80.90, suggesting a potential upside of 5.63%. Given Evolent Health's stronger consensus rating and higher probable upside, analysts plainly believe Evolent Health is more favorable than V2X.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evolent Health	1 Sell rating(s)	4 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.65
V2X	1 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.46

Summary

V2X beats Evolent Health on 10 of the 16 factors compared between the two stocks.

How does Evolent Health compare to Flywire?

Evolent Health (NYSE:EVH) and Flywire (NASDAQ:FLYW) are both computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends.

Flywire has lower revenue, but higher earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than Flywire, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evolent Health	$1.88B	0.33	-$534.51M	-$4.76	N/A
Flywire	$623.03M	3.49	$13.50M	$0.23	76.65

In the previous week, Flywire had 1 more articles in the media than Evolent Health. MarketBeat recorded 2 mentions for Flywire and 1 mentions for Evolent Health. Evolent Health's average media sentiment score of 1.00 beat Flywire's score of 0.93 indicating that Evolent Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Evolent Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Flywire	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Flywire has a net margin of 4.45% compared to Evolent Health's net margin of -26.29%. Flywire's return on equity of 3.78% beat Evolent Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evolent Health	-26.29%	0.36%	0.10%
Flywire	4.45%	3.78%	2.61%

95.9% of Flywire shares are owned by institutional investors. 1.5% of Evolent Health shares are owned by insiders. Comparatively, 5.0% of Flywire shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Evolent Health currently has a consensus price target of $6.08, suggesting a potential upside of 8.92%. Flywire has a consensus price target of $18.07, suggesting a potential upside of 2.50%. Given Evolent Health's higher possible upside, equities analysts clearly believe Evolent Health is more favorable than Flywire.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evolent Health	1 Sell rating(s)	4 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.65
Flywire	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.73

Evolent Health has a beta of 0.76, indicating that its share price is 24% less volatile than the broader market. Comparatively, Flywire has a beta of 1.32, indicating that its share price is 32% more volatile than the broader market.

Summary

Flywire beats Evolent Health on 13 of the 17 factors compared between the two stocks.

Get Evolent Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EVH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EVH vs. The Competition

Export

Metric	Evolent Health	INTERNET SOFTWARE Industry	Computer Sector	NYSE Exchange
Market Cap	$616.40M	$17.61B	$38.47B	$23.55B
Dividend Yield	N/A	3.38%	3.19%	4.01%
P/E Ratio	-1.17	66.93	168.83	30.81
Price / Sales	0.33	37.72	599.15	21.17
Price / Cash	1.17	77.39	45.01	25.14
Price / Book	1.58	6.80	9.47	4.74
Net Income	-$534.51M	$385.08M	$1.07B	$1.07B
7 Day Performance	-2.09%	-0.33%	-1.20%	-1.02%
1 Month Performance	18.05%	3.33%	-0.88%	0.91%
1 Year Performance	-50.85%	-10.96%	139.03%	15.73%

Evolent Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EVH Evolent Health	2.1916 of 5 stars	$5.58 +1.8%	$6.08 +8.9%	-52.7%	$616.40M	$1.88B	N/A	4,200	News Coverage Positive News Gap Down
PAGS PagSeguro Digital	4.8599 of 5 stars	$9.14 +0.2%	$12.00 +31.3%	-5.0%	$2.55B	$3.65B	6.72	9,772	Options Volume
TNET TriNet Group	3.1778 of 5 stars	$55.23 +0.0%	$55.80 +1.0%	-23.8%	$2.54B	$4.94B	16.49	3,400
PAYO Payoneer Global	3.969 of 5 stars	$7.09 flat	$7.40 +4.4%	+5.0%	$2.37B	$1.05B	35.45	2,540
VVX V2X	3.3476 of 5 stars	$73.95 -0.2%	$80.90 +9.4%	+55.2%	$2.32B	$4.48B	26.51	16,200

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:EVH) was last updated on 7/9/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Evolent Health (EVH) Competitors

EVH vs. PAGS, TNET, PAYO, VVX, and FLYW

How does Evolent Health compare to PagSeguro Digital?

Summary

How does Evolent Health compare to TriNet Group?

Summary

How does Evolent Health compare to Payoneer Global?

Summary

How does Evolent Health compare to V2X?

Summary

How does Evolent Health compare to Flywire?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EVH vs. The Competition

Evolent Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Evolent Health (EVH) Competitors

EVH vs. PAGS, TNET, PAYO, VVX, and FLYW

How does Evolent Health compare to PagSeguro Digital?

Which has more risk and volatility, PAGS or EVH?

Which has preferable earnings & valuation, PAGS or EVH?

Do analysts rate PAGS or EVH?

Does the media favor PAGS or EVH?

Do insiders & institutionals have more ownership in PAGS or EVH?

Is PAGS or EVH more profitable?

Summary

How does Evolent Health compare to TriNet Group?

Which has stronger valuation and earnings, EVH or TNET?

Does the media favor EVH or TNET?

Do institutionals and insiders have more ownership in EVH or TNET?

Which has more risk and volatility, EVH or TNET?

Do analysts recommend EVH or TNET?

Is EVH or TNET more profitable?

Summary

How does Evolent Health compare to Payoneer Global?

Do institutionals and insiders believe in PAYO or EVH?

Is PAYO or EVH more profitable?

Does the media favor PAYO or EVH?

Which has more risk and volatility, PAYO or EVH?

Do analysts recommend PAYO or EVH?

Which has better valuation and earnings, PAYO or EVH?

Summary

How does Evolent Health compare to V2X?

Do institutionals and insiders hold more shares of EVH or VVX?

Does the media prefer EVH or VVX?

Which has higher valuation & earnings, EVH or VVX?

Which has more risk and volatility, EVH or VVX?

Is EVH or VVX more profitable?

Do analysts prefer EVH or VVX?

Summary

How does Evolent Health compare to Flywire?

Which has higher valuation & earnings, EVH or FLYW?

Does the media favor EVH or FLYW?

Is EVH or FLYW more profitable?

Do institutionals & insiders hold more shares of EVH or FLYW?

Do analysts rate EVH or FLYW?

Which has more volatility and risk, EVH or FLYW?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EVH vs. The Competition

Evolent Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools